Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (Q73875926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

A Tomokuni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Aikoh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Matsuki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Y Isozaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Otsuki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Kita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Ueki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Kusaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Kishimoto

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Ueki

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

303-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

Silica-induced scleroderma

7 November 2019

cites work

1 reference

12 December 2020

Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis

1 reference

12 December 2020

CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells

1 reference

12 December 2020

Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations

1 reference

12 December 2020

Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases

1 reference

12 December 2020

The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis

1 reference

12 December 2020

Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis

1 reference

12 December 2020

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

12 December 2020

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

1 reference

12 December 2020

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

12 December 2020

Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly.

1 reference

12 December 2020

Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.

1 reference

12 December 2020

Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy

1 reference

12 December 2020

Polyclonal human T-cell activation by silicate in vitro

1 reference

12 December 2020

Immunotoxicology of silica

1 reference

12 December 2020

Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease

1 reference

12 December 2020

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

12 December 2020

Leukocyte immunophenotypes in bronchoalveolar lavage fluid and peripheral blood of paracoccidioidomycosis, sarcoidosis and silicosis

1 reference

12 December 2020

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

12 December 2020

Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis

1 reference

12 December 2020

Activation of human CD4+CD45RA+ T cells by chrysotile asbestos in vitro

1 reference

12 December 2020

Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica.

1 reference

12 December 2020

10.1111/J.1365-2249.1997.TB08332.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9367417%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference